Merck & Co., Inc.
The Associate Principal Scientist will develop 3D translational stem cell models and functional multi-omics platforms to advance biomarker discovery and target validation within the Discovery Immunology Therapeutic Area. This role involves designing and executing hands-on laboratory experiments, integrating multimodal data types, and collaborating with cross-functional teams to generate actionable biological insights. The position supports discovery-stage programs by contributing to innovative human translational models and data-driven research.
Headquarters
Rahway, New Jersey, United States
Company Size
10001+ employees
Founded
1891
Merck is a global science company focused on improving health by following the science to tackle some of the world’s greatest health threats. The company concentrates its efforts on research and development to deliver medicines, vaccines, and health solutions that improve lives. By applying scientific discovery to real-world needs, Merck translates breakthroughs into accessible therapies and preventive measures worldwide. With a global footprint and a commitment to science-driven innovation, Merck aims to advance health outcomes and make a lasting impact on patients and communities.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Merck & Co., Inc..
35% above the average for this role
Associate Principal Scientist
MSD
Vice President, Translational Medicine
Annexon Biosciences
Translational Science Director Immunology Cell Therapy
AstraZeneca
Translational Science Director Immunology Cell Therapy
AstraZeneca
Translational Science Lead
AstraZeneca
Sr. Scientist/Principal Scientist, Translational Research and Clinical Biomarkers (Immunology)
Antares Therapeutics